Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis

Daniel R. Altmann; Bas Jasperse; Frederik Barkhof; K. Beckmann; Massimo Filippi; L. D. Kappos; P. D. Molyneux; Chris H. Polman; Carlo Pozzilli; Alan J. Thompson; K. Wagner; Tarek Yousry; D. H. Miller

doi:10.1212/01.wnl.0000335765.55346.fc

Related publications

Article2000

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis

P. D. Molyneux, Ludwig Kappos, Chris H. Polman, Carlo Pozzilli, Frederik Barkhof, Massimo Filippi, Tarek Yousry, David W. Hahn, Klaus Wagner, Mahdiyeh Khabbaz Koche Ghazi, K. Beckmann, Frank Dahlke, Nicholas Losseff, Gareth J. Barker, Alan J. Thompson, D. H. Miller

Article1995

Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis.

Massimo Filippi, A. Campi, S. Mammì, Vittorio Martinelli, T. Locatelli, Giuseppe Scotti, Stefano Amadio, N. Canal, Giancarlo Comi

Letter2017

Simvastatin and cognition in multiple sclerosis

Massimo Filippi, Maria A. Rocca

Article2004

Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis

Maria Pia Sormani, Marco Rovaris, Paola Valsasina, Jerry S. Wolinsky, Gıancarlo Comı, Massimo Filippi

Article2008

Sample sizes for brain atrophy outcome measures in clinical trials for secondary progressive multiple sclerosis

D. R. Altmann, Bas Jasperse, Frederik Barkhof, K. Beckmann, Massimo Filippi, Ludwig Kappos, P. D. Molyneux, CH Polman, Carlo Pozzilli, Alan J. Thompson, K. Wagner, Tarek Yousry, D. H. Miller, Euspms Mri SubStudy